Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × talazoparib × Clear all

NCT05071937 2025-06-22

ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms